Skip to main content
. 2019 Jun 18;2019(6):CD008215. doi: 10.1002/14651858.CD008215.pub3

Venn 1995.

Methods Retrospective cohort, Ausralia, 1978 to 1992, 1 centre
Participants Women treated or referred for IVF with known age and time of entry to cohort, N = 10,358, median age 32 (range 18 to 49), median age at the end of the follow‐up 38 (range 21 to 57) in exposed (N = 5564).Median age 31 (range 19 to 51), median age at the end of the follow‐up 38 (range 22 to 59) in unexposed (4794).
Interventions Infertility treatment, type of treatment CC/HCG/HMG, dosage NR, 2052 women underwent 1 cycle, 1362 2 cycles, 1637 between 3 and 5 cycles and 191 more than 6 cycles.
Outcomes Ovarian cancer by histological diagnosis from the Victorian Cancer Registry
Notes Total person‐years contributed was 31,272 for the exposed group and 35,655 for the unexposed group. Median length of follow‐up for exposed 5.2 (range 1 to 15.1), median length follow‐up for unexposed 7.6 (range 1 to 15.5)
Risk of bias
Bias Authors' judgement Support for judgement
Selection bias Low risk No person had ovarian cancer at the start of the study and at least with one ovary
Confounding High risk No adjusted analysis was reported and groups were not matched or balanced for confounding factors at baseline
Performance bias High risk Medical records, no blinding of assessors to exposure status reported
Detection bias High risk Cancer registry, no blinding of assessors to case status
Attrition bias Low risk 67% for exposed group and 71% for the unexposed.
Selective reporting (reporting bias) Low risk All the infertility drugs used were reported.